Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Nazca
Mexico CityPre-Seed–Late Stage
32 people
Taiwania Capital
TaipeiSeed–Growth
49 people
Presidio Ventures
Silicon ValleySeed–Growth$500K – $5M
26 people
Pemba Capital Partners Pty Ltd.
SydneyGrowth$6.6M – $19.8M
47 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Halifax Group
WashingtonGrowth$40M – $80M
39 people
Nexxus Capital
Mexico CityGrowth$15M – $50M
50 people
Mid Europa Partners
WarsawGrowth$55M – $330M
43 people
Amethis
ParisGrowth
59 people
Eurazeo
ParisSeed–Late Stage
35 people
Parthenon
BostonGrowth
41 people
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
Johnson & Johnson Innovation – JJDC
New BrunswickSeed–Growth
42 people
BaltCap
TallinnGrowth$5.4M – $21.6M
23 people
Endeavour Capital
PortlandGrowth$35M – $100M
35 people
OceanSound Partners
New YorkGrowth
60 people
Lee Equity Partners
New YorkGrowth
59 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
44 people
Korys
HalleGrowth$5.4M
40 people
Olive Tree Capital
BostonSeed–Growth
6 people
redalpine
ZugSeed–Growth$108K – $2.2M
28 people
Ironwood Capital
AvonGrowth$10M – $50M
19 people
Coral Capital
TokyoPre-Seed–Growth$500K – $5M
24 people
Nippon Sangyo Suishin Kiko
TokyoGrowth
54 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.









































































































